Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury

Experimental Neurology

Volumn 164, Issue 2, 2000, Pages 426-437

  Hains, Bryan C ^a,b   Chastain, Kathy M ^a,b   Everhart, Alex W ^b   McAdoo, David J ^a,b   Hulsebosch, Claire E ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Adrenal medullary chromaffin cells; Allodynia; Catecholamines; Chronic central pain; Hemisection; Spinal cord injury; Transplantation

Indexed keywords

ADRENALIN; ANTINOCICEPTIVE AGENT; CATECHOLAMINE; DOPAMINE; NORADRENALIN; OPIATE PEPTIDE; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ALLODYNIA; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL TRANSPLANTATION; CEREBROSPINAL FLUID EXAMINATION; CHROMAFFIN CELL; CHRONIC PAIN; CONTROLLED STUDY; FORELIMB; GRAFT SURVIVAL; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINDLIMB; IMMUNOREACTIVITY; LOCOMOTION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; TREATMENT OUTCOME;

EID: 0034528448     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7439     Document Type: Article

References (106)

1. Effects of selective spinal cord lesions on the spinal motor evoked potential (MEP) in the rat
2. Transplantation in humans of encapsulated xenogenic cells without immunosuppression
3. Effects of selective spinal cord lesions on the spinal motor evoked potential (MEP) in the rat
4. Reflex mechanisms of interlimb interrelationships displayed in lumbar flexor centers of the cat spinal cord
5. A sensitive and reliable locomotor rating scale for open field testing in rats
6. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
7. Central dysesthesias syndrome in spinal cord injury patients
8. Epidural and spinal anesthesia
9. One-year chromaffin cell allograft survival in cancer patients with chronic pain: Morphological and functional evidence
10. Neural transplantation - An experimental tool with clinical possibilities
11. Disturbances in cutaneous sensibility in patients with central pain caused by the spinal cord lesions of syringomyelia
12. Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury
13. Lectures on the physiology and pathology of the central nervous system and on the treatment of organic nervous affections
14. Clinical implications of recent advances in neurotrauma research
15. Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience
16. Pain and depression in acute traumatic spinal cord injury: Origins of chronic problematic pain?
17. Descending adrenergic input to the primate spinal cord and possible role in modulation of spinothalamic cells
18. The adrenal chromaffin cell
19. Spinal descent of cerebrospinal fluid in man
20. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain
21. Mechanical and thermal allodynia in chronic central pain following spinal cord injury
22. Chronic central pain after spinal cord injury
23. Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat
24. The effects of dorsal rhizotomy and spinal cord isolation on calcitonin generelated peptide labeled terminals in the rat lumbar dorsal horn
25. Epidural neural blockade
26. Regional distribution of the locomotor pattern-generating network in the neonatal rat spinal cord
27. Update on cellular transplantation into the CNS as a novel therapy for chronic pain
28. The influence of xenotransplant immunogenicity and immunosuppression on host MHC expression in the rat CNS
29. Clinical characteristics of central (Dysesthetic) pain in spinal cord injury patients
30. Fetal spinal cord transplants support the development of target reaching and coordinated postural adjustments after neonatal cervical spinal cord injury
31. Autoradiographic distribution of the D1 agonst [3H]SKF38393, in the rat brain and spinal cord. Comparision with the distribution of D2 dopamine receptor
32. Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors, and chromaffin cell plasticity
33. The primate spinocervicothalamic pathway: Responses of cells of the lateral cervical nucleus and spinocervical tract to innocuous and noxious stimuli
34. Changes in GAD- and GABA- immunore-activity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplants of immortalized serotonergic precursors
35. Lumbar transplants of immortalized serotonergic neurons alleviate chronic neuropathic pain
36. Spinal cholinergic and monoamine receptors mediate the antinociceptive effect of morphine microinjected in the periaqueductal gray on the rat tail, but not the feet
37. Functional brain tissue transplantation: Reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts
38. Intrastriatal adrenal medulla grafts in rats. Long-term survival and behavioral effects
39. Effects of adrenal medulla and sciatic nerve co-grafts in rats with unilateral substantia nigra lesions
40. Effects of hemorrhage and opiate antagonists on adrenal release of neuropeptides in cats
41. Locomotion in vertebrates: Central mechanisms and reflex interaction
42. Le syndrome de brownsequard d'origine traumatique
43. Reduction of chronic central pain following spinal cord injury by transplants of adrenal medullary chromaffin cells
44. Modulation of NMDA receptor expression in the rat spinal cord by peripheral nerve injury and adrenal medullary grafting
45. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
46. Transplants enhance locomotion in neonatal kittens whose spinal cords are transection: A behavioral and anatomical study
47. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts
48. Propriospinal control of interneurons in spinal reflex pathways from tendon organs in the cat
49. Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons
50. HPLC assays of noradrenaline and dopamine in CSF samples from drug-free subjects
51. Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principal sensory nucleus in patients with spinal cord transection
52. Experimental deafferentation syndromes
53. Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers
54. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells
55. Denervation-induced intraspinal synaptogenesis of calcitonin gene-related peptide containing primary afferent terminals
56. Intraspinal sprouting of calcitonin gene-related peptide containing primary afferents after deafferentation in the rat
57. Problems of long-term spinal opioid treatment in advanced cancer pain
58. Purification of adrenal chromaffin cells increases antinociceptive efficacy of transplants without immunosuppression
59. Coordination of movements of the hindlimbs and forelimbs indifferent forms of locomotion in normal and decerebrate cats
60. Lamina IV-VI neurons of the second sacral segment projecting to the sixth cervical segment of the cats spinal cord
61. Syringomyelia and syringobulbia
62. The actions of noradrenaline on neurons of the rat substantia gelatinosa
63. Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS
64. Relief of intractable cancer pain by human chromaffin cell transplants: Experience at two medical centers
65. Further evidence for the existence of long ascending unmyelinated primary afferent fibers within the dorsal funiculus: Effects of capsaicin
66. Mechanisms underlying antinociception produced by heterosegmental noxious stimulation in the rat tail-flick test
67. Adrenocortical control of epinephrine synthesis
68. Intrathecal administration of norepinephrine (NE) into the lumbar subarachnoid space of rats and cats implanted with chronic spinal catheters produced a strong, dose-dependent, behaviorally defined analgesia
69. The clinical features of central pain
70. Extensive dual innervation and mutual inhibition by forelimb and hindlimb inputs to ventroposterolateral nucleus projection neurons in the rat
71. Increased levels of metenkephalin-like immunoreactivity in the spinal-cord CSF of rats with adrenal medullary transplants
72. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity
73. Alleviation of pain in cancer patients by adrenal medullary transplants in the spinal subarachnoid space
74. Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model
75. Spinal cord: Connections
76. Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation
77. Flexion-reflex of the limb, crossed extension-reflex, and reflex stepping and standing
78. Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants
79. A natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model
80. Alterations in rat spinal cord cGMP by peripheral nerve injury and adrenal medullary transplantation
81. Responses of long descending propriospinal neurons to natural and electrical types of stimuli in cat
82. Somatosensory response properties of contralaterally projecting spinothalamic and nonspinothalamic neurons in the second cervical segment of the cat
83. Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord
84. Spinal cord compression studies. II. Time limits for recovery after acute compression in dogs
85. Analysis of calcitonin gene-related peptide-like immunoreactivity in the cat dorsal spinal cord and dorsal root ganglia provide evidence for a multisegmental projection of nociceptive C-fiber primary afferents
86. The trophic cocktail made by adrenal chromaffin cells
87. Differentiation and transplantation of adrenal chromaffin cells of the guinea pig
88. Can mechanisms of central pain syndromes be investigated in animal models?
89. Attenuation of pain-related hyperventilation in adjuvant arthritic rats with adrenal medullary transplants in the spinal subarachnoid space
90. Direct catecholaminergic innervation of primate spinothalamic tract neurons
91. Noradrenergic innervation of the somatosensory thalamus and spinal cord
92. Effects of iontophoretically released amino acids and amines on primate spinothalamic tract cells
93. Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture
94. Subarachnoid adrenal medullary transplants for terminal cancer pain
95. Antinociception following implantation of AtT-20 and genetically modified AtT-20/hENK cells in rat spinal cord
96. Implantation of atT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance
97. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing
98. Resting and K+-evoked release of serotonin and norephinephrine in vivo from the rat and cat spinal cord
99. Pain following spinal cord injury: The clinical problem and experimental studies
100. Excitotoxic spinal cord injury: Behavioral and morphological characteristics of a central pain model
101. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury
102. Immunoisolating encapsulation of intrathecally implanted bovine chromaffin cells prolongs their survival and produces antiallodynic effects in spinally injured rats
103. Transplant therapy: Recovery of function after spinal cord injury